Dr. Eimear Kenny, Ph.D., is a Professor of Medicine and Genetics, and the Founding Director of the Institute for Genomic Health, at the Icahn School of Medicine at Mount Sinai. 

She is a renowned expert in population genetics and translational genomics. She leads a multidisciplinary team of geneticists, computer scientists, and clinician scientists, working on problems at the interface of genetic ancestry, machine learning, and medicine. 

Her research is focused on uncovering the clinical impact of human genetic variation and accelerating the implementation of genomic information in routine clinical care in diverse populations. Her work seeks to build better tools, resources, and best practices to broaden diversity and representation in genomic research and ameliorate health disparities in the implementation of genomic medicine. 

Dr. Kenny uses data science from extensive databases of genomic information to improve human health through population and statistical genetics, machine-learning approaches for discovering rare and common diseases, genomic risk prediction for preventive health; clinical trials in genomic medicine; and a digital app development for precision medicine. 

She is Principal Investigator in 6 large national programs focused on genomic research, medicine, and health. She was recently awarded the 2022 Early-career award from the American Society of Human Genetics. She is a scientific advisor to many genomic and genomic medicine initiatives in government, non-profit, and industry arenas. She has published over 170 papers in leading journals like Science, Nature, Nature Genetics, and NEJM, with over 20,000 citations. Her work has been featured by many media outlets, including the New York Times.

She has a BA in Biochemistry from Trinity College Dublin, a Ph.D. in computational genomics from Rockefeller University, and did her postdoctoral training in population genetics at Stanford University. ♦